Monoacylglycerol lipase inhibitors: modulators for lipid metabolism in cancer malignancy, neurological and metabolic disorders
Potential application of endocannabinoid system agents in neuropsychiatric and neurodegenerative diseases—focusing on FAAH/MAGL inhibitors | Acta Pharmacologica Sinica
Overview of current clinical studies of MAGL inhibitor 21 (ABX-1431). | Download Scientific Diagram
A Reversible and Selective Inhibitor of Monoacylglycerol Lipase Ameliorates Multiple Sclerosis - Hernández‐Torres - 2014 - Angewandte Chemie International Edition - Wiley Online Library
Monoacylglycerol lipase inhibitors: modulators for lipid metabolism in cancer malignancy, neurological and metabolic disorders - ScienceDirect
Synthesis and biological evaluation of novel tanshinone IIA derivatives for treating pain
Therapeutic endocannabinoid augmentation for mood and anxiety disorders: comparative profiling of FAAH, MAGL and dual inhibitors | Translational Psychiatry
Monoacylglycerol lipase (MAGL) as a promising therapeutic target - ScienceDirect
Potential application of endocannabinoid system agents in neuropsychiatric and neurodegenerative diseases—focusing on FAAH/MAGL inhibitors | Acta Pharmacologica Sinica
Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo | PNAS
Representative small molecule MAGL inhibitors. | Download Scientific Diagram
APExBIO - Monoacylglycerol Lipase Inhibitor 21 inhibitor of monoacylglycerol lipase (MAGL) and FAAH | CAS# 1643657-35-5
Monoacylglycerol lipase inhibitors: modulators for lipid metabolism in cancer malignancy, neurological and metabolic disorders - ScienceDirect
MAGL-IN-4 | MAGL Inhibitor | MedChemExpress
Elevating endocannabinoid levels: pharmacological strategies and potential therapeutic applications | Proceedings of the Nutrition Society | Cambridge Core
A Schematic model of the effects of MAGL inhibition on the interactions... | Download Scientific Diagram
Monoacylglycerol lipase inhibitors: modulators for lipid metabolism in cancer malignancy, neurological and metabolic disorders - ScienceDirect
Anticancer Potential of Small‐Molecule Inhibitors of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase - Jaiswal - 2021 - ChemMedChem - Wiley Online Library
Chemical approaches to therapeutically target the metabolism and signaling of the endocannabinoid 2-AG and eicosanoids - Chemical Society Reviews (RSC Publishing) DOI:10.1039/C4CS00047A
Inhibitors of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase: New Targets for Future Antidepressants | Bentham Science
Discovery of Trifluoromethyl Glycol Carbamates as Potent and Selective Covalent Monoacylglycerol Lipase (MAGL) Inhibitors for Treatment of Neuroinflammation | Journal of Medicinal Chemistry
Monoacylglycerol lipase inhibitors: modulators for lipid metabolism in cancer malignancy, neurological and metabolic disorders - ScienceDirect
Overview of current clinical studies of MAGL inhibitor 21 (ABX-1431). | Download Scientific Diagram
